StocksToTrade

Stock screening and analysis platform.

3.7

editorial rating

·SubscriptionLow risk

Last updated May 29, 2026

Quick verdict — is StocksToTrade worth it?

A low-risk, useful option for market analysis. Our editorial rating is 3.7/5, with a 70/100 trust score and low scam-risk. Pricing starts at From ~$50/mo.

Overview

StocksToTrade is stock screening and analysis platform. It targets business use cases on paid plans. The rating, trust score and scam-risk signal below are informational estimates compiled from public information, product documentation and user-submitted reviews — not factual claims about the company.

How to read this: Scores are informational estimates from public information, product docs and user-submitted reviews — not factual claims about any company. A higher scam-risk signal reflects user-reported concerns or unverified marketing, not proven wrongdoing. Always confirm current pricing and terms with the provider.

The verdict

A low-risk, useful option for market analysis.

Pros

Powerful screening
News & charts
Paper trading

Cons

Pricey
Informational only — not advice

Best for

Market analysis
Charting
Tracking watchlists

Not great for

Guaranteed returns (no tool offers these)
Risk-free investing

Main features

Market analysis

Charting & signals

Alerts

Data dashboards

Pricing breakdown

Popular

Pro

$50

per month

Full access
All core features
Support

Pricing shown is an informational estimate and may change. Confirm on the official site before purchasing.

Our editorial review

Reviewed by Priya Nair, Trust & Safety EditorUpdated May 29, 2026 · How we review

StocksToTrade is stock screening and analysis platform, aimed at business.

Its main strengths are powerful screening and news & charts. The trade-offs to weigh are pricey and informational only — not advice. Pricing and billing appear transparent with no notable red flags in aggregated user reports.

A low-risk, useful option for market analysis.

What is StocksToTrade?

At its core, StocksToTrade positions itself as an AI trading tool aimed at businesses and teams. The product is aimed at businesses and teams, which is worth keeping in mind when you weigh it against more general-purpose alternatives. Where it tends to win people over is powerful screening, backed up by news & charts. Like every tool in this space, it is not a silver bullet, and we cover the trade-offs below.

StocksToTrade pricing and value

StocksToTrade is priced from From ~$50/mo. Since it is paid-only, treat any introductory trial as your evaluation period and confirm it fits your workflow before the first full charge. As with most software, the per-month price only makes sense if the tool removes a bottleneck you hit regularly. We did not find a meaningful pattern of billing complaints, which is a positive signal for a tool at this price point.

Who should use StocksToTrade?

StocksToTrade makes the most sense for businesses and teams who need an trading tool that delivers powerful screening. People most often reach for it on routine trading tool work — the kind of repetitive tasks where automation pays off fastest. Where we would steer you elsewhere is pricey and informational only — not advice — if those are dealbreakers, test thoroughly before relying on it.

Is StocksToTrade trustworthy and safe?

On trust, StocksToTrade lands in the moderate band, which is our compiled read of reputation, billing clarity and how realistic its claims are. The scam-risk signal is Low, meaning we did not surface the patterns — opaque billing, blocked cancellations, or wildly unrealistic promises — that warrant extra caution. None of this replaces your own due diligence: confirm the latest pricing, privacy practices and refund policy on the official site before deciding. Specific points users have raised include: A market tool, not financial advice; trading carries risk of loss.

StocksToTrade review: the bottom line

The bottom line: StocksToTrade is a mixed pick for the right user. Provided powerful screening matters more to you than the downside of pricey, it belongs on your list. Use any available trial to validate quality, and prefer a monthly plan until you are confident. We keep these reviews current as the market shifts — the update date above reflects our latest pass.

Potential red flags

A market tool, not financial advice; trading carries risk of loss

Positive signals

Clear, published pricing
Active product with a real user base
No significant billing complaints in aggregated reports

How we scored trust

An informational composite of the signals below. Not a factual judgment about the company.

User rating77

Review volume57

Billing clarity63

Refund policy clarity63

Support responsiveness63

Website transparency63

Realistic claims63

Public reputation63

Our read on public sentiment

Users generally find StocksToTrade mixed, with feedback centering on pricey rather than trust or billing problems.

This is our editorial summary of publicly-available user feedback and reviews from around the web — not reviews collected on this site. Verified reviews submitted here appear in the section below.